Interview: Christopher Cogle
Professor Christopher Cogle argues that the healthcare innovation ecosystem focuses too heavily on FDA approval while neglecting the practical challenges of affordability and accessibility. He advocates for innovators to prioritize the end-user's ability to receive treatment from the earliest stages of development.
Why it matters
This perspective highlights a critical systemic gap in medical innovation, where scientifically advanced treatments often fail to reach the patients who need them most due to economic barriers.
Christopher Cogle | Professor, University of Florida; Director, Florida Health Policy Leadership Academy, Gainesville, USA
The article presents a professional critique of industry incentives, focusing on policy and implementation rather than partisan politics.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in